Co-infection and Cancer (R21 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- PAR-25-083
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.399 Cancer Control
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Independent School Districts
- Tribal Organizations (Not Federally Recognized)
- Small Businesses
- Higher Education Inst. (Public)
- For Profit Organizations
- Other
- Tribal Governments (Federally Recognized)
- Non-501(c)(3) Nonprofits
- City/Township Governments
- County Governments
- 501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- State Governments
- Public or Indian Housing Auth.
- Special District Governments
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer. The goal is to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. The Department of Health and Human Services' National Institutes of Health is seeking applications from a wide range of eligible applicant types, including independent school districts, non-profit organizations, small businesses, and higher education institutions. Preference will be given to investigations of co-infections with known oncogenic agents (excluding HIV) and of co-infections that engender novel opportunities for prevention and treatment.
The funding will be provided in the form of grants under the "Cancer Control" federal grant program (CFDA 93.399). While the FOA does not specify award amounts or deadlines, recent Federal Grant Awards under the Cancer Control program have ranged from approximately $450,000 to over $8 million, with project periods typically spanning 3-5 years. The work is expected to be conducted at the applicant institutions across the United States.
Synopsis
The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. Co-infection is defined as the occurrence of infections by two or more infectious (pathogenic or non-pathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms. Preference will be given to investigations of co-infections with known oncogenic agents (excluding human immunodeficiency virus [HIV]) and of co-infections that engender novel opportunities for prevention and treatment.
Files
| File | Type | Posted |
|---|---|---|
| PAR-25-083-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity